Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

1 February 2007

Volume 195, Number 3
The Journal of Infectious Diseases 2007;195:416–424
0022-1899/2007/19503-0016$15.00
DOI: 10.1086/510755
MAJOR ARTICLE

Rapid, Real‐Time Detection of Acute HIV Infection in Patients in Africa

Susan A. Fiscus,1

Christopher D. Pilcher,2

William C. Miller,2,3

Kimberly A. Powers,3

Irving F. Hoffman,2

Matthew Price,3,a

David A. Chilongozi,4

Clement Mapanje,4

Robert Krysiak,2

Syze Gama,4

Francis E. A. Martinson,4

Myron S. Cohen,1,2 and the

Malawi–University of North Carolina Project Acute HIV Infection Study Teamb

Departments of 1Microbiology and Immunology, 2Medicine, and 3Epidemiology, University of North Carolina (UNC) at Chapel Hill, Chapel Hill; 4UNC Project, Lilongwe Central Hospital, Lilongwe, Malawi

Background.We conducted a prospective study to evaluate methods of detecting clients with sexually transmitted diseases (STDs) who were acutely coinfected with human immunodeficiency virus (HIV) in Lilongwe, Malawi.

Methods.After informed consent was obtained, all clients with acute STDs were offered voluntary HIV counseling and testing by 2 rapid antibody tests. Samples from rapid test–negative or –discordant subjects were pooled (50:5:1) and tested for HIV RNA. Western blots were performed on all rapid test–discordant specimens with detectable HIV RNA. A subset of specimens received p24 antigen testing with standard and/or ultrasensitive methods. Patients with possible acute HIV infection were followed to confirm seroconversion.

Results.A total of 1450 clients (34% female and 66% male) agreed to testing, of whom 588 (40.55%) had established HIV infection and 21 (1.45%) had acute infection. Discordant rapid antibody tests identified 7 of 21 (33.3% sensitivity), standard p24 antigen identified 12 of 16 (75% sensitivity), and ultrasensitive p24 antigen identified 15 of 17 (88% sensitivity) acute cases. By definition, the sensitivity of the RNA assay was 100%.

Conclusions.Real‐time pooled RNA testing for the detection of acute HIV infection is feasible in resource‐limited settings. However, parallel rapid testing and p24 antigen testing are technologically simpler and together may detect 90% of acute cases.

Received 1 June 2006; accepted 22 September 2006; electronically published 22 December 2006.

Reprints or correspondence: Dr. Susan A. Fiscus, Dept. of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599‐7290 ().

Cited by

Alison E. Brown, Robert J. Gifford, Jonathan P. Clewley, Claudia Kucherer, Bernard Masquelier, Kholoud Porter, Claudia Balotta, Nicole K. T. Back, Louise Bruun Jorgensen, Carmen de Mendoza, Krishnan Bhaskaran, O. Noel Gill, Anne M. Johnson, and Deenan Pillay, on behalf of the Concerted Action on Seroconversion to AIDS and Death in Europe (CASCADE) Collaboration. (2009) Phylogenetic Reconstruction of Transmission Events from Individuals with Acute HIV Infection: Toward More‐Rigorous Epidemiological Definitions. The Journal of Infectious Diseases 199:3, 427-431
Online publication date: 1-Feb-2009.
A. Ren, B. Louie, L. Rauch, L. Castro, S. Liska, J. D. Klausner, M. W. Pandori. (2008) Screening and confirmation of human immunodeficiency virus type 1 infection solely by detection of RNA. Journal of Medical Microbiology 57:10, 1228-1233
Online publication date: 1-Nov-2008.
CrossRef
Cynthia L. Gay, Myron S. Cohen. (2008) Antiretrovirals to prevent HIV infection: Pre-and postexposure prophylaxis. Current Infectious Disease Reports 10:4, 323-331
Online publication date: 1-Aug-2008.
CrossRef
Raúl Ortiz de Lejarazu, Vincent Soriano, José M. Eiros, Manuel Arias, and Carlos Toro. (2008) HIV‐1 Infection in Persistently HIV‐1–Seronegative Individuals: More Reasons for HIV RNA Screening. Clinical Infectious Diseases 46:5, 785-785
Online publication date: 1-Mar-2008.
Linda Gelgor, John Kaldor. (2008) Epidemiology of primary HIV-1 infection. Current Opinion in HIV and AIDS 3:1, 4-9
Online publication date: 1-Feb-2008.
CrossRef
Eric S Daar, Christopher D Pilcher, Frederick M Hecht. (2008) Clinical presentation and diagnosis of primary HIV-1 infection. Current Opinion in HIV and AIDS 3:1, 10-15
Online publication date: 1-Feb-2008.
CrossRef
Kimberly A Powers, William C Miller, Christopher D Pilcher, Clement Mapanje, Francis EA Martinson, Susan A Fiscus, David A Chilongozi, David Namakhwa, Matthew A Price, Shannon R Galvin, Irving F Hoffman, Myron S Cohen. (2007) Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm. AIDS 21:16, 2237-2242
Online publication date: 1-Nov-2007.
CrossRef
Rachel Smith, Nicola M Zetola, Jeffrey D Klausner. (2007) Beyond the end of exceptionalism: integrating HIV testing into routine medical care and HIV prevention. Expert Review of Anti-infective Therapy 5:4, 581-589
Online publication date: 1-Sep-2007.
CrossRef
David M. Margolis and Nancie M. Archin. (2007) Eliminating Persistent HIV Infection: Getting to the End of the Rainbow. The Journal of Infectious Diseases 195:12, 1734-1736
Online publication date: 15-Jun-2007.
  • Potential conflicts of interest: none reported.

    Presented in part: 2nd International Workshop on Acute HIV Infection, Washington, DC, 4–5 May 2004 (abstract T‐04); 12th Conference on Retroviruses and Opportunistic Infections, Boston, MA, February 22–26, 2005 (abstract 20).

    Financial support: National Institutes of Health (grants R37 DK49381, 5 P30 AI50410, 5U19 AI031496, K23 AI01781, R01 MH68686, and ST32 AI07701‐29).

  • Present affiliation: International AIDS Vaccine Initiative, New York, New York.

  • Other study team members are listed after the text.

Close Popup